Food & Food Contact Materials
CIRS Group
Chemicals
Cosmetic
Food
Medical Devices
Agrochemicals
CIRS Testing
Carbon Neutrality
Search
Q&A
Recently, China’s Food Evaluation Center of the State Administration for Market Regulation released answers to frequently asked questions about infant formula product formulation.
In our previous articles, we have translated the frequently asked questions regarding the health food acceptance and the application of infant formula products in China. Today, we will continue with the FAQs on the application of food for special medical purposes in China.
To accurately address the common questions frequently encountered in the acceptance of special foods and related administrative licenses, and to effectively improve applicants’ efficiency and experience, the Food Review Center of the State Administration for Market Regulation issued the “Summary of Common Issues on the Acceptance Work” on October 28, 2025.
To accurately address the common questions frequently encountered in the acceptance of special foods and related administrative licenses, and to effectively improve applicants’ efficiency and experience, the Food Review Center of the State Administration for Market Regulation issued the “Summary of Common Issues on the Acceptance Work” on October 28, 2025.
FAQs on the Replacement of Health Food Registration Certificate in China (Vol. 4)
FAQs on the Replacement of Health Food Registration Certificate in China (Vol. 3)
FAQs on the Replacement of Health Food Registration Certificate in China (Vol. 2)
On April 25, 2025, we hosted a free Chinese webinar on the key points and considerations in food registration in different countries and US food label compliance. Many questions were raised during the webinar.We have collected the questions and made a Q&A summary.
On April 23, the State Administration for Market Regulation (SAMR) of China issued the Q&A on the Registration of Foods for Special Medical Purposes Infant Formula under the New National Standard (hereinafter referred to as the “Q&A”). The purpose of the Q&A is to facilitate the re-registration process following the promulgation of the National Food Safety Standard - General Rules for Food for Special Medical Purpose Infant Formula (GB 25596—2025) (hereinafter referred to as the “New National Standard”), guide enterprises in the standardized submission of applications, and ensure a smooth market transition.
We have collected frequently asked questions on the dietary supplement in the United States for your reference.